Veloxis Pharmaceuticals AS:企業の戦略的SWOT分析

◆英語タイトル:Veloxis Pharmaceuticals AS - Strategic SWOT Analysis Review
◆商品コード:GDPH61177SA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Veloxis Pharmaceuticals AS – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Veloxis Pharmaceuticals A/S (Veloxis), a subsidiary of Asahi Kasei Corp, is a specialty pharmaceutical company that identifies, develops and commercializes pharmaceutical drugs in transplantation and adjacent therapies. The company lead product is ENVARSUS XR (tacrolimus extended-release tablets) for the prophylaxis of organ rejection in kidney transplant patients. ENVARSUS is developed based on the company’s proprietary, patented drug delivery technology, MeltDose, which is designed to enhance the absorption and bioavailability of select orally administered drugs. The company sells ENVARSUS XR to government agencies, specialty pharmacies, managed healthcare organizations, wholesalers and retail customers across the US, Europe and worldwide. Veloxis is headquartered in Copenhagen, Denmark.

Veloxis Pharmaceuticals AS Key Recent Developments

Jan 29,2020: Nasdaq Copenhagen has accepted Veloxis Pharmaceuticals request for Delisting of its Shares from Nasdaq Copenhagen
Nov 26,2019: Asahi Kasei offers to buy Veloxis Pharmaceuticals for $1.3bn
Nov 12,2019: Veloxis Pharmaceuticals announces financial results for the first nine months of 2019
Aug 08,2019: Veloxis Pharmaceuticals announces financial results for the first six months of 2019
Jul 22,2019: Veloxis revises outlook for 2019 based on strong performance

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Veloxis Pharmaceuticals AS – Key Facts
Veloxis Pharmaceuticals AS – Key Employees
Veloxis Pharmaceuticals AS – Key Employee Biographies
Veloxis Pharmaceuticals AS – Major Products and Services
Veloxis Pharmaceuticals AS – History
Veloxis Pharmaceuticals AS – Company Statement
Veloxis Pharmaceuticals AS – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Veloxis Pharmaceuticals AS – Business Description
Veloxis Pharmaceuticals AS – SWOT Analysis
SWOT Analysis – Overview
Veloxis Pharmaceuticals AS – Strengths
Veloxis Pharmaceuticals AS – Weaknesses
Veloxis Pharmaceuticals AS – Opportunities
Veloxis Pharmaceuticals AS – Threats
Veloxis Pharmaceuticals AS – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Veloxis Pharmaceuticals AS, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Veloxis Pharmaceuticals AS, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Veloxis Pharmaceuticals AS, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jan 29, 2020: Nasdaq Copenhagen has accepted Veloxis Pharmaceuticals request for Delisting of its Shares from Nasdaq Copenhagen
Nov 26, 2019: Asahi Kasei offers to buy Veloxis Pharmaceuticals for $1.3bn
Nov 12, 2019: Veloxis Pharmaceuticals announces financial results for the first nine months of 2019
Aug 08, 2019: Veloxis Pharmaceuticals announces financial results for the first six months of 2019
Jul 22, 2019: Veloxis revises outlook for 2019 based on strong performance
May 06, 2019: Veloxis Pharmaceuticals announces financial results for the first three months of 2019
Feb 27, 2019: Veloxis Pharmaceuticals releases annual report for 2018
Jan 03, 2019: Mark Hensley promoted to Chief Commercial Officer of Veloxis Pharmaceuticals
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Veloxis Pharmaceuticals AS, Key Facts
Veloxis Pharmaceuticals AS, Key Employees
Veloxis Pharmaceuticals AS, Key Employee Biographies
Veloxis Pharmaceuticals AS, Major Products and Services
Veloxis Pharmaceuticals AS, History
Veloxis Pharmaceuticals AS, Subsidiaries
Veloxis Pharmaceuticals AS, Key Competitors
Veloxis Pharmaceuticals AS, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Veloxis Pharmaceuticals AS, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Veloxis Pharmaceuticals AS, Recent Deals Summary

★海外企業調査レポート[Veloxis Pharmaceuticals AS:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pernix Therapeutics Holdings Inc (PTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR …
  • Bouwinvest Real Estate Investment Management B.V.:企業の戦略・SWOT・財務情報
    Bouwinvest Real Estate Investment Management B.V. - Strategy, SWOT and Corporate Finance Report Summary Bouwinvest Real Estate Investment Management B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Siltech Corp:企業の戦略的SWOT分析
    Siltech Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tenet Healthcare Corporation:企業の戦略・SWOT・財務情報
    Tenet Healthcare Corporation - Strategy, SWOT and Corporate Finance Report Summary Tenet Healthcare Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • GAIL (India) Ltd (GAIL)-エネルギー分野:企業M&A・提携分析
    Summary GAIL (India) Ltd (GAIL) is a vertically integrated gas company that carries out exploration and production, transmission of natural gas. It also has presence in petrochemical, liquid hydrocarbons and power and renewable sectors. GAIL is also a major LPG transmission company, besides managing …
  • Bioanalytical Systems Inc (BASI):企業の財務・戦略的SWOT分析
    Summary Bioanalytical Systems Inc (Bioanalytical Systems) is a contract research organization. It provides drug discovery and development services, and analytical instruments. The company’s contract research services include screening and pharmacological testing, formulation development, preclinical …
  • China General Nuclear Power Corp:電力:M&Aディール及び事業提携情報
    Summary China General Nuclear Power Corp (CGN), formerly China Guangdong Nuclear Power Group (CGNPC) is a clean energy company that offers clean energy products and renewable energy services. The company's products include nuclear power and HPR1000, among others. It offers services such as nuclear p …
  • Greenbelt Resources Corp (GRCO):電力:M&Aディール及び事業提携情報
    Summary Greenbelt Resources Corp (GRC) is an alternative energy company that offers sustainable energy production systems delivering modular solutions that enable localized processing of locally generated waste into locally consumed products. The company designs, develops and implements technology t …
  • Jamnica dd:企業の戦略・SWOT・財務分析
    Jamnica dd - Strategy, SWOT and Corporate Finance Report Summary Jamnica dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • TomTom NV (TOM2):企業の財務・戦略的SWOT分析
    TomTom NV (TOM2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Seoul City Gas Co Ltd (017390):企業の財務・戦略的SWOT分析
    Seoul City Gas Co Ltd (017390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Toshiba Corporation:企業の戦略・SWOT・財務情報
    Toshiba Corporation - Strategy, SWOT and Corporate Finance Report Summary Toshiba Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Iluka Resources Ltd:企業の戦略・SWOT・財務情報
    Iluka Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Iluka Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • SP Transmission plc:企業の戦略的SWOT分析
    SP Transmission plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Korea Electric Power Corporation (015760):企業の財務・戦略的SWOT分析
    Korea Electric Power Corporation (015760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Canadian Natural Resources, Ltd.:企業の戦略・SWOT・財務分析
    Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Sanovas Inc-医療機器分野:企業M&A・提携分析
    Summary Sanovas Inc (Sanovas) focuses on the development of minimally invasive diagnostic and therapeutic technologies and solutions. The company provides imaging technologies, interventional lung, interventional ENT, and interventional uro and gyn products. Its imaging technologies product provides …
  • Sanford Health:医療機器:M&Aディール及び事業提携情報
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center provides medical services in the areas of allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding d …
  • Grant Thornton International Ltd.:企業の戦略・SWOT・財務分析
    Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Mapletree Investments Pte Ltd:企業の戦略的SWOT分析
    Mapletree Investments Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆